The global active pharmaceutical ingredients (API) market reached a value of US$ 200.6 Billion in 2020. Active pharmaceutical ingredient (API), is the term that is used to refer to the biologically active component of a drug (e.g. tablet, capsule). A drug is usually composed of several components. The API represents the primary ingredient. Other ingredients are commonly known as "excipients. Sometimes a drug can contain several APIs and its effect on a patient depends on the dosage prescribed and can vary from person to person. In combination therapies, two or more than two active ingredients are used to treat different symptoms in different ways. Stringent quality control is a mandate when it comes to the manufacturing of drugs as the API represents the main component considered while making the prescription.
Pharmaceutical manufacturing occurs in two general steps. In the first step, manufacturers convert raw materials into APIs. The second step involves creating the final formulation by mixing APIs and excipients into tablets, capsules, solutions, etc. and finally packaging the drug for the end users. Manufacturers either sell APIs in the open market (also known as the merchant market) or use them as inputs to make their final formulations. The global API market is extremely competitive with a number of large and small manufacturers. Firms that engage in API manufacturing generally specialize and target their manufacturing based on a combination of the firms in-house skills and market opportunities. Catalyzed by lower costs, API manufacturing has gradually been shifting from the historical leaders in Western countries to manufacturers based in India and China.
The global demand of APIs is currently exhibiting strong growth. One of the major drivers of this market is the rising number of blockbuster patent expiries creating a significant opportunity for generic APIs. Moreover, there has been a strong demand for APIs for biologicals. The global market for biologicals is currently exhibiting strong growth catalyzed by their high potency and ability to treat diseases beyond the scope of small molecule drugs. This is creating a strong demand for APIs for branded biological drugs and their biosimilar versions. Other factors catalyzing the global demand of APIs include ageing population, rising expenditures on healthcare, increasing prevalence of lifestyle diseases, etc. Looking forward, the analyst expects the global active pharmaceutical ingredients (API) market to exhibit moderate growth during the forecast period (2021-2026).
Breakup by Drug Type: Innovative Active Pharmaceutical Ingredients (API) Generic Active Pharmaceutical Ingredients (API)
Based on the drug type, the market has been segmented as innovative active pharmaceutical ingredients and generic active pharmaceutical ingredients.
Breakup by Manufacturer: Captive Manufacturers Merchant API Manufacturers Innovative Merchant API Manufacturers Generic Merchant API Manufacturers
Based on the type of manufacturer, the market has been segmented as captive manufacturers and merchant API manufacturers.
Breakup by Synthesis
Synthetic Active Pharmaceutical Ingredients (API) Market Breakup by Type Innovative Synthetic APIs Generic Synthetic APIs Biotech Active Pharmaceutical Ingredients (API) Market Breakup by Type Innovative Biotech APIs Biosimilars Market Breakup By Product Monoclonal Antibodies Vaccines Cytokines Fusion Proteins Therapeutic Enzymes Blood Factors Market Breakup By Expression System Mammalian Expression Systems Microbial Expression Systems Yeast Expression Systems Transgenic Animal Systems Others
Based on the type of synthesis, the market has been segmented as synthetic active pharmaceutical ingredients and biotech active pharmaceutical ingredients.
Breakup by Therapeutic Application: Oncology Cardiovascular and Respiratory Diabetes Central Nervous System Disorders Neurological Disorders Others
Based on the therapeutic application, the market has been segmented as oncology, cardiovascular & respiratory, diabetes, central nervous system disorders, neurological disorders and others.
Breakup by Region: North America United States Canada Europe Germany France United Kingdom Italy Spain Russia Others Asia Pacific China Japan India South Korea Australia Indonesia Others Latin America Middle East and Africa
Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Competitive Landscape: The competitive landscape of the market has also been examined with some of the (active pharmaceutical ingredients companies) key players being Pfizer, Inc., Novartis International AG, Sanofi, Boehringer Ingelheim, Bristol-Myers Squibb, Teva Pharmaceutical Industries Ltd., ELI Lilly and Company, GlaxoSmithKline, Merck & Co., Inc. and Abbvie Inc.
Key Questions Answered in This Report: How has the global active pharmaceutical ingredients (API) market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global active pharmaceutical ingredients (API) industry? What are the key regional markets in the global active pharmaceutical ingredients (API) industry? What is the breakup of the global active pharmaceutical ingredients (API) market on the basis of drug type? What is the breakup of the global active pharmaceutical ingredients (API) market on the basis of type of manufacturer? What is the breakup of the global active pharmaceutical ingredients (API) market on the basis of synthesis? What is the breakup of the global active pharmaceutical ingredients (API) market on the basis of therapeutic application? What are the various stages in the value chain of the global active pharmaceutical ingredients (API) market? What are the key driving factors and challenges in the global active pharmaceutical ingredients (API) market? What is the structure of the global active pharmaceutical ingredients (API) market and who are the key players? What is the degree of competition in the global active pharmaceutical ingredients (API) market? How are active pharmaceutical ingredients (API) manufactured?
Our reports have been used by over 10K customers, including:
The Neurodegenerative Disease market was valued at approximately USD 39.24 billion in 2020 and is expected to witness a revenue of USD 44.90 billion in 2026, with a CAGR of 2.30% over the forecast period. The COVID-19 impact on the Neurodegenerative Disease market is expected to be significant as the pandemic has impacted the workflows...
Executive Summary Global Hexamethyldisilazane Market was valued at USD 202.32 Million and xx Kilotonne by volume in the year 2020. Hexamethyldisilane (HMDS) is an organosilicon compound used as a reagent or precursor to bases and is primarily used as a silylating agent in the process of manufacturing pharmaceutical drugs...
5-Hydroxytryptamine Receptor 7 - Drugs In Development, 2021 Summary According to the recently published report ’5-Hydroxytryptamine Receptor 7 - Drugs In Development, 2021’; 5-Hydroxytryptamine Receptor 7 (5 HT7 or 5 HTX or Serotonin Receptor 7 or HTR7) pipeline Target constitutes close to 15 molecules....
Mergers and Acquisitions (M&A) in the Pharmaceutical Contract Manufacturing Industry - Implications and Outlook - 2021 Edition
This report is the third edition of our analysis of mergers and acquisitions in the pharmaceutical contract manufacturing industry. PharmSource is the most definitive,...
266 pages •
By Asia Market Information & Development Company
• Jul 2021
China’s demand for Fasteners has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption...
175 pages •
By The Business Research Company
• Jun 2021
Major players in the fertility drugs market are Merck & Co., Ferring Pharmaceuticals, Bayer, Berlex Laboratories Inc., Janssen Pharmaceutical Inc., Pfizer, Novartis AG, Procter & Gamble Pharmaceutical, Zydus Pharma and LIVZON. The global drugs for infertility market is expected to grow from $3.48 billion in 2020 to $3.94 billion in...
The APAC advanced planning and scheduling (APS) software market is expected to grow from US$ 432.75 million in 2020 to US$ 917.09 million by 2028; it is estimated to grow at a CAGR of 10.0% from 2021 to 2028. Manufacturing operations digitalization is expected fuel the APAC advanced planning and scheduling (APS) software market growth. Digital...
243 pages •
By Global Industry Analysts
• May 2021
Global Microcrystalline Cellulose (MCC) Market to Reach $1.6 Billion by 2027
Amid the COVID-19 crisis, the global market for Microcrystalline Cellulose (MCC) estimated at US$940.9 Million in the year 2020, is projected to reach a revised size of US$1.6 Billion by 2027, growing at...
The global lactose powder market reached a volume of 865 Kilotons in 2020. Lactose is naturally found in milk and milk-based products. It is a vital component of whey and aids in optimizing milk calcium usage by improving intestinal absorption and dairy protein assimilation. Lactose powder is a white, inert and water-soluble...
The global magnetic stirrer market reached a value of US$ 1.97 Billion in 2020. A magnetic stirrer, also known as a magnetic mixer, is a laboratory equipment comprising a rotating magnet or stationary electromagnet that generates a rotating magnetic field to stir fluids and create a homogenous mixture. The process of magnetic stirring helps...
Research And Development
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.